Grant: CIHR Fellowship
Direct Payment
$110,000.00
Genetic determinants of vaccine responses: a multi-ancestry human leukocyte antigen and genome-wide association study with implications for vaccine development
FY 2021-22
Summary
Genetic variation is associated with susceptibility to infectious diseases and is also a likely key determinant of how well the immune system responds to vaccination. Since genetics can help design better treatments, understanding genetic determinants of immunity could help design better vaccines.
However, there are two specific challenges with genetic determinant of vaccine response. First, most of our current knowledge is derived from European ancestry populations, but due to living in areas of high infectious diseases endemicity, non-European populations would likely benefit the most from vaccine genetic breakthroughs. Second, of particular interest to vaccine response is the human leukocyte antigen (HLA) system, a highly polymorphic segment of chromosome 6, which varies widely between different populations. The HLA requires dedicated analysis due to its complex architecture. Hence, there is a need for this research, especially in under-represented populations in large scale genetics research.
In this program, we will measure the association between the genotype of 5150 individuals of diverse genetic ancestries and their vaccine responses. Study participants will come from 6 countries: Uganda, Burkina Faso, South Africa, Kenya, United Kingdom, and Bangladesh. This will ensure adequate genetic diversity for our analysis. We will perform genome-wide and HLA association studies on antibody response to diphtheria, tetanus, pertussis, hepatitis B, measles, pneumococcus, and polio vaccines. We will leverage our sample's genetic diversity to help shed light on the HLA by combining our results using random effect meta-analysis methods. Finally, we will follow-up on our results with modern bioinformatics methods to determine how best to translate our results to better treatment and vaccines for patients.
Department
Program
CIHR Fellowship
Recipient
Location
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
454419
Name
Butler-Laporte Guillaume
Country
United Kingdom
Orgtype
Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
Genetic determinants of vaccine responses: a multi-ancestry human leukocyte antigen and genome-wide association study with implications for vaccine development
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$110,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Genetic Epidemiology; Genome-Wide Association Study; Human Leukocyte Antigen; Infectious Diseases; Vaccines
Abstract
Genetic variation is associated with susceptibility to infectious diseases and is also a likely key determinant of how well the immune system responds to vaccination. Since genetics can help design better treatments, understanding genetic determinants of immunity could help design better vaccines.
However, there are two specific challenges with genetic determinant of vaccine response. First, most of our current knowledge is derived from European ancestry populations, but due to living in areas of high infectious diseases endemicity, non-European populations would likely benefit the most from vaccine genetic breakthroughs. Second, of particular interest to vaccine response is the human leukocyte antigen (HLA) system, a highly polymorphic segment of chromosome 6, which varies widely between different populations. The HLA requires dedicated analysis due to its complex architecture. Hence, there is a need for this research, especially in under-represented populations in large scale genetics research.
In this program, we will measure the association between the genotype of 5150 individuals of diverse genetic ancestries and their vaccine responses. Study participants will come from 6 countries: Uganda, Burkina Faso, South Africa, Kenya, United Kingdom, and Bangladesh. This will ensure adequate genetic diversity for our analysis. We will perform genome-wide and HLA association studies on antibody response to diphtheria, tetanus, pertussis, hepatitis B, measles, pneumococcus, and polio vaccines. We will leverage our sample's genetic diversity to help shed light on the HLA by combining our results using random effect meta-analysis methods. Finally, we will follow-up on our results with modern bioinformatics methods to determine how best to translate our results to better treatment and vaccines for patients.
Competitiondate
202110
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Butler-Laporte, Guillaume
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $110,000~ $0~